About EARLYDIAGNOSTICS INC
EarlyDiagnostics (EarlyDx) is a company focused on providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine. They offer technologies such as CancerRadar and EarlyDx-Cloud for cancer detection and bioinformatics solutions.
Development of liquid biopsy tests for early cancer detectionCreation of non-invasive blood tests for cancer detection and monitoringBioinformatics solutions for liquid biopsy through EarlyDx-CloudMethylation-based liquid biopsy platform for hepatocellular carcinoma (HCC) detectionCancer recurrence and evolution monitoring
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC 428 - NCI SBIR TRANSITION TO PHASE II SOLICITATION FY 2023 | Department of Health and Human Services | $2.0M | |
| Federal contract award | Department of Health and Human Services | $396K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EARLYDIAGNOSTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.